Qureight
Qureight
Qureight
An end-to-end imaging company providing enterprise-grade imaging and precision endpoints for clinical trials, focusing on lung and heart disease.
About
What does Qureight do?
Qureight is a MedTech company that provides an end-to-end AI-powered imaging platform for clinical trials, with a specific focus on lung and heart disease. They leverage 3D deep-learning imaging and AI-powered biomarkers to analyze complex medical images, identify disease progression, and accelerate drug discovery and development for biopharmaceutical companies. The platform aims to improve clinical trial design and efficiency by automating image management and providing precise clinical trial e…
What is Qureight's Effective Domain Rating?
StartupHub's Effective Domain Rating for Qureight is 49 out of 100, measuring real cross-surface visibility in search engines and AI answers rather than claimed link authority. That is underrated against its Ahrefs Domain Rating of 28, meaning it surfaces in search and AI results more than its claimed authority alone would suggest.
Is Qureight trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Qureight is 47 out of 100, a use-caution rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
What is Qureight's revenue?
StartupHub estimates Qureight's annual revenue at $2.1M (range $631K to $7.9M, 35% confidence), based on comparable companies in the sector.
What is Qureight's valuation?
StartupHub estimates Qureight's effective valuation at $80.0M (range $50.0M to $120.0M, 25% confidence), based on comparable companies in the sector.
How much funding has Qureight raised?
Qureight has raised a total of $20M in funding. The most recent round on record is Series B.
Where is Qureight headquartered?
Qureight is headquartered in Cambridge, United Kingdom.
When was Qureight founded?
Qureight was founded in 2018.
What industry does Qureight operate in?
Qureight operates in Biotechnology, Artificial Intelligence, Healthcare, Clinical Trials, MedTech, HealthTech.
“CPIX | CUMBERLAND PHARMACEUTICALS PARTNERS WITH QUREIGHT TO ADVANCE INNOVATIVE IDIOPATHIC PULMONARY FIBROSIS TREATMENT RESEARCH.”
View on Reddit“Rein Therapeutics and Qureight Ltd Announce Planned Integration of Deep-Learning Platform for Phase 2 Trial of LTI-03 in Patients with IPF.”
View on Reddit“Data analytics company Qureight has entered into a multi-year strategic research collaboration with AstraZeneca that will use AI models to accelerate research into lung diseases.”
View on Reddit“Data analytics company Qureight has entered into a multi-year strategic research collaboration with AstraZeneca that will use AI models to accelerate research into lung diseases.”
View on Reddit“Data analytics company Qureight has entered into a multi-year strategic research collaboration with AstraZeneca that will use AI models to accelerate research into lung diseases.”
View on RedditSome comments are pulled from public discussions around the web (look for the source icon). Quotes are excerpts; click through to read the full thread.